Showing results (111-120 of 561) with videos related to

Sort By:
Pageof 57
European Heart Journal Open|March 13, 2026
Pericardiocentesis vs. surgical pericardial window for first occurrence of malignancy-related pericardial effusion: a meta-analysis of retrospective studiesTarek Nahle, Aditya Bhave, Karl Abou Zeid, et al.
European Heart Journal Open|March 13, 2026
Insulin resistance and metabolic health predict cardiorespiratory fitness: cohort studyLiliana Muñoz-Hernandez, Ana Leonor Rivera, Adrian Soto-Mota, et al.
European Heart Journal Open|March 13, 2026
A rapid review and narrative synthesis of the evidence for oral sodium chloride supplements in the management of heart failureJoseph J Cuthbert, Dionisius R Ardiyanto, Omar Amin, et al.
European Heart Journal Open|March 6, 2026
Right ventricular global constructive work as an echocardiographic predictor of worsening heart failureAram Chilingaryan, Lusine Tunyan, Hamlet Hayrapetyan, et al.
European Heart Journal Open|June 12, 2026
Outcomes after inhospital, subacute, and elective TAVI in COMPARE-TAVI 1Troels Thim, Henrik Nissen, Phillip Freeman, et al.
European Heart Journal Open|June 12, 2026
Baseline characteristics of patients enrolled in the AZIMUTH trial: an e-health-integrated, smartphone app-based model of care for heart failure patientsDomenico D'Amario, Donato Antonio Paglianiti, Renzo Laborante, et al.
European Heart Journal Open|June 12, 2026
Correction to: Outcomes of catheter ablation for ventricular tachycardia in structural heart disease: a meta-analysis and quality appraisal of trials
European Heart Journal Open|June 12, 2026
Prevalence and incidence of left ventricular systolic dysfunction and adverse outcomes in patients receiving de novo and replacement pacemaker therapy for bradycardiaNurul H Abdul Samad, John Gierula, Judith E Lowry, et al.
European Heart Journal Open|June 12, 2026
Asymptomatic and symptomatic cardiac toxicity associated with immune checkpoint inhibitors: insights from a Japanese registryYudai Tamura, Yuichi Tamura, Hiroshi Ohtsu, et al.
European Heart Journal Open|April 20, 2026
Moderate-dose doxorubicin does not affect right ventricular size or function parameters in lymphoma patients-a single-center studyEduardo Brenner-Muslera, Maria F Gomez-Ardila, Eduardo Tellez-Garcia, et al.
Pageof 57